Deerfield Management Company, L.P. (Series C) Global Blood Therapeutics, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

  • $5.38 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$41.72 - $87.2 $10.5 Million - $21.9 Million
-251,000 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$45.7 - $81.86 $781,470 - $1.4 Million
-17,100 Reduced 6.38%
251,000 $20 Million
Q3 2019

Nov 14, 2019
BUY
$45.35 - $57.91 $1.5 Million - $1.92 Million
33,100 Added 14.09%
268,100 $13 Million
Q2 2019

Aug 14, 2019
BUY
$52.6 - $63.29 $12.4 Million - $14.9 Million
235,000 New
235,000 $12.4 Million

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email